The document discusses medical management strategies for male infertility. It begins by stating that empirical medical treatment of idiopathic oligozoospermia is generally not effective. Specific medical therapies are recommended for subclinical male genital tract infections and hypogonadism. Hormonal therapy with hCG is the treatment of choice for adult-onset hypogonadotropic hypogonadism. Aromatase inhibitors may help overweight or obese men with aromatase hyperactivity and oligozoospermia. Antioxidants, antibiotics, anti-inflammatories and antihistamines have shown promise in treating subclinical male genital tract infections and reducing sperm DNA damage.